We are live on ! Find out more
ELEV

Elevation Oncology

Delisted

ELEV was delisted on the 22nd of July, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
ACM
1
Aisling Capital Management
New York
$3.97M
QUSVM
2
Qiming U.S. Ventures Management
Washington
$3.32M
BI
3
BVF Inc
California
$3.24M +$5 +2 +0%
CAM
4
Cormorant Asset Management
Massachusetts
$2.78M +$8 +3 +0%
VP
5
venBio Partners
California
$2.61M -$1.86M -741,828 -28%
BC
6
Boxer Capital
California
$1.22M
SB
7
Samsara BioCapital
California
$1.16M -$255K -101,675 -11%
TCM
8
TCG Crossover Management
California
$777K
Vanguard Group
9
Vanguard Group
Pennsylvania
$561K +$62K +24,700 +7%
SCM
10
Sio Capital Management
New York
$504K
Renaissance Technologies
11
Renaissance Technologies
New York
$362K +$585K +233,000 +917%
Janus Henderson Group
12
Janus Henderson Group
$250K -$2.34M -930,732 -84%
BCM
13
Bridgeway Capital Management
Texas
$219K +$251K +100,000 +177%
KCM
14
Kennedy Capital Management
Missouri
$210K +$341K +135,863 +968%
CC
15
Caxton Corporation
New Jersey
$96K +$35 +14 +0%
MAM
16
Marquette Asset Management
Minnesota
$55K
BlackRock
17
BlackRock
New York
$52K -$1.27K -507 -1%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$36K
VF
19
Virtu Financial
New York
$31K +$54.7K +21,798 New
Millennium Management
20
Millennium Management
New York
$30K +$54.2K +21,573 New
State Street
21
State Street
Massachusetts
$26K
TRCT
22
Tower Research Capital (TRC)
New York
$8K +$8.35K +3,327 +162%
Osaic Holdings
23
Osaic Holdings
Arizona
$2K
Barclays
24
Barclays
United Kingdom
$1K
SPIA
25
Steward Partners Investment Advisory
New York
$1K